TVM Capital Life Science Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
10
- Investments
-
77
- Portfolio
-
22
- Exits
-
48
TVM Capital Life Science General Information
Company Description
Founded in 1983, TVM Capital Life Science is a venture capital investment firm headquartered in Munich, Germany. The firm seeks to invest in biopharma, diagnostic, med-tech, and digital health companies in Europe, North America, and Asia.
Business Details
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- Ottostraße 4
- 80333 Munich
- Germany
TVM Capital Life Science Investments (77)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Anciata Therapeutics | 10-Apr-2025 | Joint Venture | Drug Discovery | Startup | ||
| Egg Medical | 01-Mar-2025 | Medical Supplies | Generating Revenue | |||
| RejuvenAir | 18-Sep-2024 | Therapeutic Devices | Generating Revenue | |||
| Leon Nanodrugs | 06-Aug-2024 | Drug Discovery | Generating Revenue | |||
| Jacobian | 22-Apr-2024 | Decision/Risk Analysis | Generating Revenue | |||
| Vektor Medical | 19-Feb-2024 | Decision/Risk Analysis | Clinical Trials - General | |||
| myo | 31-Jan-2024 | Other Healthcare Technology Systems | Generating Revenue | |||
| Mage Biologics | 20-Jul-2023 | Drug Discovery | Pre-Clinical Trials | |||
| TargaGenix | 28-Feb-2023 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Esperas Pharma | 21-Feb-2023 | Later Stage VC | Biotechnology | Out of Business |
TVM Capital Life Science Exits (48)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Esperas Pharma | 25-Apr-2026 | Out of Business | |
| Centogene | 13-Nov-2024 | ||
| Ixchelsis | 26-May-2024 | ||
| Modulate Therapeutics | 06-Oct-2023 | ||
| Direvo | 07-Oct-2021 | ||
| Rapid Micro Biosystems | 15-Jul-2021 | ||
| Mediti Pharma | 15-Apr-2021 | ||
| F-Star Therapeutics | 20-Nov-2020 | ||
| Centogene | 10-Jul-2020 | Public Investment 2nd Offering | |
| Proteon Therapeutics | 09-Jan-2020 | Merger/Acquisition |
TVM Capital Life Science Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
TVM Capital Life Science Investments by Industry, Year, and Region
TVM Capital Life Science Co-Investors (34)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Ascension Ventures | 1 |
|
|
||
| First Analysis |
|
|
|||
| Intersouth Partners |
|
|
|||
| SV Health Investors |
|
|
|||
| TVM Capital |
|
|
TVM Capital Life Science Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Tvm Vi Lsv Beteiligungsgesellschaft mbH | Munich, Germany | 2004 | |
| Tvm Iv Beteiligungsgesellschaft mbH | Munich, Germany | 2000 |
TVM Capital Life Science FAQs
-
What is TVM Capital Life Science?
Founded in 1983, TVM Capital Life Science is a venture capital investment firm headquartered in Munich, Germany.
-
When was TVM Capital Life Science founded?
TVM Capital Life Science was founded in 1983.
-
Where is TVM Capital Life Science headquartered?
TVM Capital Life Science is headquartered in Munich, Germany.
-
What is TVM Capital Life Science's total asset value?
TVM Capital Life Science has around in total assets under management.
-
How many investments has TVM Capital Life Science made?
TVM Capital Life Science has made 77 investments.
-
What has TVM Capital Life Science invested in?
TVM Capital Life Science has made numerous investments in companies like Anciata Therapeutics, Egg Medical, and RejuvenAir within the Drug Discovery, Medical Supplies, and Therapeutic Devices industries.
-
What has TVM Capital Life Science invested in recently?
TVM Capital Life Science's latest investment was on 10-Apr-2025 in Anciata Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process